Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Merck & Co. Inc., consolidated balance sheet: assets (quarterly data)

US$ in millions

	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cash and cash equivalents	8,629)	13,242)	14,593)	11,304)	5,579)	6,841)	8,605)	5,660)	9,707)	12,694)	11,145)	9,675)	8,556)	8,096)	10,016)	8,575)	6,981)	8,062)	7,356)	11,103)	7,425)
Short-term investments	599)	447)	—)	50)	40)	252)	168)	718)	680)	498)	103)	453)	372)	—)	—)	—)	—)	—)	—)	—)	7)
Accounts receivable, net of allowance for doubtful accounts	10,790)	10,278)	11,381)	11,642)	11,366)	10,349)	10,394)	11,030)	10,415)	9,450)	9,482)	9,643)	9,828)	9,230)	8,571)	7,843)	8,235)	7,851)	8,422)	7,577)	8,182)
Inventories, excludes inventories classified in Other assets	6,196)	6,109)	6,244)	6,469)	6,510)	6,358)	6,131)	5,930)	5,863)	5,911)	5,614)	5,535)	5,774)	5,953)	5,603)	5,499)	6,402)	6,310)	6,128)	6,056)	5,846)
Other current assets	9,289)	8,706)	8,143)	8,740)	7,950)	8,368)	6,656)	6,639)	6,737)	7,169)	7,217)	6,810)	6,654)	6,987)	6,868)	6,748)	5,291)	5,541)	4,671)	4,607)	4,714)
Current assets	35,503)	38,782)	40,361)	38,205)	31,445)	32,168)	31,954)	29,977)	33,402)	35,722)	33,561)	32,116)	31,184)	30,266)	31,058)	28,665)	26,909)	27,764)	26,577)	29,343)	26,174)
Investments	616)	463)	575)	357)	280)	252)	1,306)	1,214)	1,290)	1,015)	984)	238)	316)	370)	435)	411)	544)	785)	1,372)	1,251)	555)
Property, plant and equipment, at cost, net of accumulated depreciation	24,793)	23,779)	23,446)	23,221)	23,045)	23,051)	22,526)	22,231)	21,758)	21,422)	20,424)	20,059)	19,747)	19,279)	18,565)	18,064)	18,295)	17,986)	16,919)	15,789)	15,269)
Goodwill	21,684)	21,668)	21,697)	21,161)	21,181)	21,197)	21,183)	21,195)	21,209)	21,204)	21,160)	21,213)	21,258)	21,264)	18,862)	18,873)	20,212)	20,238)	20,248)	20,067)	19,767)
Other intangibles, net	15,758)	16,370)	17,010)	16,984)	17,572)	18,011)	19,199)	19,665)	19,857)	20,269)	21,368)	22,497)	23,022)	22,933)	13,384)	13,622)	14,401)	14,604)	16,677)	16,566)	16,096)
Other assets	16,768)	16,044)	14,443)	12,702)	12,326)	11,996)	10,559)	10,187)	10,280)	9,528)	9,584)	10,972)	11,141)	11,582)	11,190)	11,053)	10,486)	10,211)	8,007)	7,599)	7,052)
Noncurrent assets	79,619)	78,324)	77,171)	74,425)	74,404)	74,507)	74,773)	74,492)	74,394)	73,438)	73,520)	74,979)	75,484)	75,428)	62,436)	62,023)	63,938)	63,824)	63,223)	61,272)	58,739)
Total assets	115,122)	117,106)	117,532)	112,630)	105,849)	106,675)	106,727)	104,469)	107,796)	109,160)	107,081)	107,095)	106,668)	105,694)	93,494)	90,688)	90,847)	91,588)	89,800)	90,615)	84,913)

Cash and cash equivalents: The cash position displayed fluctuations, beginning at $7,425 million in March 2020, rising sharply to $11,103 million by June 2020, and then experiencing volatility throughout the periods. Peaks are notable at December 2022 ($12,694 million) and September 2024 ($14,593 million), followed by downturns. The latest figure in March 2025 shows a decline to $8,629 million, reflecting a less liquid position compared to the recent highs.
Short-term investments: Data is incomplete for early periods; however, from 2021 onward, short-term investments generally present low values with noticeable variability. The highest points are $718 million in June 2021 and $680 million in March 2022, with several subsequent quarters showing low or missing data, indicating either reduced emphasis on short-term investments or possible reclassification.
Accounts receivable, net: Accounts receivable remained relatively stable with a gradual increasing trend. Starting from $8,182 million in March 2020, values climb to a peak of $11,642 million in June 2024 before slightly moderating to $10,790 million by March 2025. The overall trend suggests steady sales growth or extended credit sales terms over the period.
Inventories: Inventories exhibit modest growth and some fluctuations, beginning at $5,846 million in March 2020, peaking at $6,510 million in September 2024, then dipping slightly to $6,196 million in March 2025. This indicates relatively stable inventory management with slight increases correlating with sales or operational needs.
Other current assets: This category increased notably from $4,714 million in March 2020 to a high of $9,289 million by March 2025, showing a consistent upward trend especially after late 2022. This may reflect increased prepaid expenses, advances, or other liquid assets not classified elsewhere, signaling greater current asset buffering.
Current assets: Total current assets increased overall, with a start of $26,174 million in March 2020 and growth to $38,782 million in June 2024, followed by a slight decrease to $35,503 million as of March 2025. The upward trend points towards stronger liquidity, supported by growth in cash and other current assets despite some volatility in short-term investments.
Investments: Investments fluctuated, starting at $555 million and peaking at $1,306 million in December 2021, then declining and showing uneven patterns throughout the subsequent quarters. There is no clear upward or downward trend, which might suggest variable deployment of capital depending on market opportunities or strategic changes.
Property, plant and equipment (PP&E), net: PP&E consistently grew, moving from $15,269 million in March 2020 to $24,793 million in March 2025. This steady increase over five years suggests ongoing capital expenditures and investments in operational facilities or equipment, reflecting a long-term asset growth strategy.
Goodwill: Goodwill remained relatively stable, hovering around the $20,000 million mark, with minor fluctuations noted but no significant increases or decreases. The data indicates that little impairment or major acquisitions affecting goodwill were recorded during the period.
Other intangibles, net: Other intangibles experienced a decline overall, starting at $16,096 million in March 2020, increasing briefly to $22,933 million in December 2021, then declining to $15,758 million by March 2025. The temporary spike might be due to acquisitions or revaluations, followed by amortization and write-downs reducing the balance.
Other assets: Other assets generally increased from $7,052 million in March 2020 to $16,768 million by March 2025. This steady rise suggests accumulation of long-term assets or deferred charges, representing an expanding balance sheet composition outside core asset categories.
Noncurrent assets: Noncurrent assets maintained a generally upward trend, opening at $58,739 million in March 2020 and concluding at $79,619 million by March 2025. Minor fluctuations occurred, but the overall increase corresponds with growth in PP&E and other long-term investments.
Total assets: Total assets experienced growth from $84,913 million in March 2020 to a peak of $117,532 million in June 2024, followed by a slight decline to $115,122 million by March 2025. The increase reflects accumulation across both current and noncurrent assets, suggesting expanding operational scale and asset base over the five-year period.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

Merck & Co. Inc. (NYSE:MRK)

Balance Sheet: Assets Quarterly Data

Assets: Selected Items

Current Assets: Selected Items

Balance Sheet: Assets
Quarterly Data